1. Home
  2. FMNB vs QTTB Comparison

FMNB vs QTTB Comparison

Compare FMNB & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMNB
  • QTTB
  • Stock Information
  • Founded
  • FMNB 1887
  • QTTB 2015
  • Country
  • FMNB United States
  • QTTB United States
  • Employees
  • FMNB N/A
  • QTTB N/A
  • Industry
  • FMNB Major Banks
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • FMNB Finance
  • QTTB Health Care
  • Exchange
  • FMNB Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • FMNB 579.0M
  • QTTB 471.5M
  • IPO Year
  • FMNB N/A
  • QTTB N/A
  • Fundamental
  • Price
  • FMNB $14.37
  • QTTB $44.75
  • Analyst Decision
  • FMNB Hold
  • QTTB Strong Buy
  • Analyst Count
  • FMNB 4
  • QTTB 5
  • Target Price
  • FMNB $15.25
  • QTTB $68.80
  • AVG Volume (30 Days)
  • FMNB 84.6K
  • QTTB 117.1K
  • Earning Date
  • FMNB 10-23-2024
  • QTTB 11-03-2024
  • Dividend Yield
  • FMNB 4.69%
  • QTTB N/A
  • EPS Growth
  • FMNB N/A
  • QTTB N/A
  • EPS
  • FMNB 1.35
  • QTTB N/A
  • Revenue
  • FMNB $169,109,000.00
  • QTTB N/A
  • Revenue This Year
  • FMNB N/A
  • QTTB N/A
  • Revenue Next Year
  • FMNB $4.60
  • QTTB N/A
  • P/E Ratio
  • FMNB $10.56
  • QTTB N/A
  • Revenue Growth
  • FMNB 5.82
  • QTTB N/A
  • 52 Week Low
  • FMNB $10.38
  • QTTB $8.24
  • 52 Week High
  • FMNB $16.32
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • FMNB 42.40
  • QTTB 53.12
  • Support Level
  • FMNB $14.22
  • QTTB $39.51
  • Resistance Level
  • FMNB $15.25
  • QTTB $47.84
  • Average True Range (ATR)
  • FMNB 0.42
  • QTTB 3.43
  • MACD
  • FMNB -0.12
  • QTTB -0.69
  • Stochastic Oscillator
  • FMNB 8.43
  • QTTB 45.68

About FMNB Farmers National Banc Corp.

Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of company's revenue is derived from the bank segment.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: